E794K
Category 5 — IDR ExclusionConflictingLumenal · predictedσ-1 candidateEditorialGlutamate → Lysine at position 794 in lumenal domain. ClinVar Conflicting including Wolfram syndrome 1. AlphaMissense 0.24 (below threshold) — AM under-call. DynaMut2 ΔΔG +0.49 STABILISING. pLDDT 49 — Category 5 IDR boundary!
Interactive 3D Structure
Bond changes · DynaMut2 interaction analysis
| Interaction type | Wild-type partner | Mutant partner | Status |
|---|---|---|---|
| Ionic bond | K800 | — | Lost |
| Hydrogen bond | S792 | S792 | Preserved |
| Hydrogen bond | D797 | D797 | Preserved |
| Hydrogen bond | K800 | K800 | Preserved |
| Polar contact | S792 | S792 | Preserved |
| Polar contact | D796 | D796 | Preserved |
| Polar contact | D797 | D797 | Preserved |
| Polar contact | K800 | — | Lost |
Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.
Computational Predictions
Clinical Evidence
Observed in the general population.
Structural Context
Position 794 at pLDDT 49 — RIGHT AT the Category 5 IDR threshold. Computational predictions deserve caution. Neighbors: GLU795 (2.5 Å), ARG793 (2.5 Å), SER792 (3.8 Å).
E794K charge-flips in a borderline IDR region. ΔΔG predictions not trustworthy here. AM 0.24 below threshold but Wolfram 1 documented.
Druggability Assessment
The Atlas routes Category 5 variants to wet-lab characterization rather than computational drug discovery.
Why this matters
Feed this card to Wolfram Intelligence
Download the E794K PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.